Elevation Oncology, Inc. (ELEV) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 3 Buy, 8 Hold, 1 Sell.
The consensus price target is $9.00 (low: $8.00, high: $10.00), representing an upside of 2365.8% from the current price $0.37.
ELEV Stock — 12-Month Price Forecast
$9.00
▲ +2,365.75% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Elevation Oncology, Inc., the average price target is $9.00, with a high forecast of $10.00, and a low forecast of $8.00.
The average price target represents a +2,365.75% change from the last price of $0.37.
Highest Price Target
$10.00
Average Price Target
$9.00
Lowest Price Target
$8.00
ELEV Analyst Ratings
Hold
Based on 12 analysts giving stock ratings to Elevation Oncology, Inc. in the past 3 months
